APICA CARDIOVASCULAR
Apica Cardiovascular is a pre revenue medical device company commercializing a technology for access and closure of the heart’s apex and the peripheral vascular system. The underlying technology has applications in a number of medical procedures such as Transcatheter Heart Valves (TAVI), AAA, and LVAD implantation. The technology standardizes access and closure for large bore therapeutic devices without loss of blood via minimally invasive surgical or percutaneous access on the beating heart. The technology has progressed to the point where it has proven the initial concept in animal and cadaver models and is now moving toward initial clinical trials.
APICA CARDIOVASCULAR
Social Links:
Industry:
Health Care Information Technology Medical Device
Founded:
2009-01-01
Address:
Galway, Galway, Ireland
Country:
Ireland
Website Url:
http://www.apica.ie
Total Employee:
11+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
4.83 M EUR
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Med-Tronik
Med-Tronik conducts research and development of medical-biophysical devices.
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
SOBR Safe
SOBR Safe is a developer of the patented non-invasive alcohol detection system.
Investors List
Triventures
Triventures investment in Venture Round - Apica Cardiovascular
Seroba Life Sciences
Seroba Life Sciences investment in Venture Round - Apica Cardiovascular
Enterprise Ireland
Enterprise Ireland investment in Venture Round - Apica Cardiovascular
More informations about "Apica Cardiovascular" on Search Engine
Apica Cardiovascular - Crunchbase Company Profile & Funding
Apica Cardiovascular is a pre revenue medical device company commercializing a technology for access and closure of the heart’s apex and the peripheral vascular system. The underlying technology has applications in a number of medical procedures such as Transcatheter Heart Valves (TAVI), AAA, and LVAD implantation. The technology …See details»
Thoratec Acquires Apica Cardiovascular | tctmd.com
Jul 2, 2014 As part of the agreement, the Apica team based at facilities in Ireland and the United States will transition to Thoratec. Apica has developed a suite of implant systems and devices designed to enable transapical surgical access.See details»
Thoratec Acquires Apica Cardiovascular - PR Newswire
PLEASANTON, Calif., July 2, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing...See details»
Apica Cardiovascular receives $5.1 million investment for …
Feb 9, 2011 Apica Cardiovascular has licensed the Georgia Tech/Emory technology and will further develop the system, which will make the transapical access and closure procedure required for delivering therapeutic devices to …See details»
Thoratec acquires Apica Cardiovascular - Cardiovascular News
Jul 8, 2014 1560. Thoratec Corporation has announced that it has acquired Apica Cardiovascular Limited for an upfront cash payment of US$35 million and potential future clinical and sales milestones of up to US$40 million. As part of the agreement, the Apica team based at facilities in Ireland and the United States will transition to Thoratec.See details»
Thoratec inks $75M deal for Apica Cardiovascular - MassDevice
July 3, 2014 By Brad Perriello. Thoratec (NSDQ: THOR) said it paid $35 million up front and agreed to another $40 million in potential milestone payments for Apica Cardiovascular and its...See details»
Thoratec announces acquisition of Apica Cardiovascular
Jul 2, 2014 The company has acquired Apica Cardiovascular for an upfront cash payment of $35m and potential future clinical and sales milestones of up to $40m. Under the agreement, theSee details»
Improving Heart Surgery: Georgia Tech and Emory University …
Feb 14, 2011 Apica Cardiovascular was founded in 2009 based on technology invented by Jimenez, Thourani, Yoganathan and Thomas Vassiliades, who was an associate professor of cardiothoracic surgery at Emory University at the time. The company was named Emory University’s Startup Company of 2010. About ATDC:See details»
Galway-based medtech firm Apica sold for $75 million
Jul 4, 2014 Galway-based technology firm Apica Cardiovascular has been sold for $75 million. The medical device company was sold to Thoratec a world leader in mechanical circulatory support therapies for...See details»
Apica Cardiovascular Receives $5.1M Investment for Improved Heart ...
Feb 9, 2011 Apica Cardiovascular was founded in 2009 based on technology invented by Jimenez, Thourani, Yoganathan and Thomas Vassiliades, who was an associate professor of cardiothoracic surgery at Emory...See details»
Bay Area's Thoratec Corporation Buys Apica Cardiovascular In
Jul 7, 2014 PLEASANTON, Calif., July 2, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has acquired Apica Cardiovascular Limited ("Apica") for an upfront cash payment of $35 million and …See details»
Apica Cardiovascular Company Profile 2024: Valuation, Investors ...
Description. Developer of cardiovascular devices. The company develops transapical access and closure system that is designed to open and close the apex of a beating heart, in order to deliver large therapeutic devices into the inner chambers of the heart in a minimally invasive manner. Contact Information. Website. www.apica.ie. Ownership Status.See details»
Apica Cardiovascular | CipherBio
Apica Cardiovascular is a pre revenue medical device company commercializing a technology for access and closure of the heart’s apex and the peripheral vascular system. The underlying technology has applications in a number of medical procedures such as Transcatheter Heart Valves (TAVI), AAA, and LVAD implantation.See details»
Apica Cardiovascular | VentureRadar
Apica Cardiovascular is a medical device company dedicated to establishing a new standard of care for transapical access and closure. The Company has... ... Find out more about Apica Cardiovascular, Medical Devices and Healthtech and Life Sciences.See details»
Apica Cardiovascular - Funding, Financials, Valuation & Investors
€4.8M. in funding over 2 rounds. Their latest funding was raised on Jan 1, 2014 from a Venture - Series Unknown round. Apica Cardiovascular is funded by 3 investors. Triventures and Seroba Life Sciences are the most recent investors. Unlock for free. Funding Rounds. Number of Funding Rounds 2. Total Funding Amount. Unlock for free.See details»
Successful Clinical Use for Apica’s Transapical Access Technology
Nov 11, 2013 device. news. Successful Clinical Use for Apica’s Transapical Access Technology. Based in Ireland, Apica Cardiovascular Limited develops technologies that are all about access, designed to make aortic and mitral valve replacement and LVAD implantation possible without the need for cardiopulmonary bypass.See details»
Apica Cardiovascular receives $5.1 million in | EurekAlert!
Feb 9, 2011 Apica Cardiovascular receives $5.1 million investment for improved heart surgery system Business Announcement. Georgia Institute of TechnologySee details»
Newly CE Marked ASC™ System Aims to Standardise Transapical Heart ...
Sep 5, 2013 Apica describes its ASC system as a breakthrough enabling platform technology that can be used by surgeons, in conjunction with minimally invasive surgical techniques. It delivers large-bore therapeutic devices into the beating heart of patients with structural heart disease, via the apex.See details»
Apica Cardiovascular - Seroba Life Sciences
Apica Cardiovascular. Apica developed novel access and closure devices to assist surgeons in the treatment of structural heart disease. Apica was acquired by Thoratec in 2014. Managed by. Daniel O'Mahony. Partner. Contact Daniel.See details»
Apica Cardiovascular CEO, Founder, Key Executive Team, …
Overview & Products. Financials. People. Executives. 2. Apica Cardiovascular Management Team. 2 Team Members. Apica Cardiovascular has 2 executives. Apica Cardiovascular's current Chief Executive Officer, President is James L. Greene. Learn more by joining our daily demo.See details»